Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL525P is a processed pseudogene found in the human genome, related to the 7SL RNA gene (which encodes the RNA component of the signal recognition particle, a ribonucleoprotein complex essential for targeting nascent secretory proteins to the endoplasmic reticulum membrane)[3][5]. As a pseudogene, RN7SL525P does not encode a functional RNA or protein and is not considered a therapeutic target. There is no evidence it has a distinct biological function or known role in disease beyond its sequence similarity to functional 7SL RNA genes. Pseudogenes in general can sometimes regulate gene expression through competitive binding to regulatory RNAs, but this property has not been demonstrated for RN7SL525P specifically[4]. Note on potential issues (is_incorrect: true): - RN7SL525P is not a functional gene or protein, nor a known therapeutic target. - The name is sometimes confused with the functional *7SL RNA* gene or Signal Recognition Particle RNA, but as a pseudogene, it lacks a direct role in biological pathways, disease, or pharmacology[1][3]. - No information links RN7SL525P specifically to drug interactions, biomarkers, or safety concerns. This entry should ideally not be used for drug target databases as it does not represent a pharmacologically relevant entity. For functional studies of SRP and related pathways, refer instead to the parental 7SL RNA gene or the proteins of the SRP complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 525, pseudogene (RN7SL525P).